EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes.
OBJECTIVE
The aim of the present study was to identify whether adolescents with type 1 diabetes receiving modern multiple insulin injection therapy (MIT) have abnormal EEGs, and to elucidate possible correlations with a history of severe hypoglycaemia, poor metabolic control and nerve conduction defects.


METHODS
We investigated 35 patients (age 14-19 years) with disease duration 7.6+/-4.6 years, and 45 healthy control subjects. EEG spectral components were obtained from 15-min recordings in resting, awake subjects. Nerve conduction was measured bilaterally in motor and sensory fibres in the median, peroneal and sural nerves.


RESULTS
The EEGs of patients showed an increase in slow activity (delta and theta) and a reduction in alpha peak frequency, both of which were most pronounced in the frontal regions (p<0.001). They also showed a decrease in fast activity, which was most pronounced bilaterally in the posterior temporal regions (alpha p<0.001, beta p<0.01, gamma p<0.001). A history of severe hypoglycaemia was correlated with a global increase in theta activity (p<0.01-0.05). Poor metabolic control, measured as acute and long-term HbA1c levels, was correlated with an increase in delta activity and a decrease in alpha peak frequency. The decrease in fast activity in the temporal regions was a separate type of abnormality because it had a different distribution, and was not correlated with the increase in delta/theta power, poor metabolic control or with hypoglycaemia.


CONCLUSIONS
Recurrent severe hypoglycaemia and poor metabolic control are risk factors for EEG abnormalities in adolescents with type 1 diabetes receiving MIT treatment. In addition, we found pronounced abnormalities in the temporal regions that were not related to these risk factors.
Hyllienmark
L
L
Department of Clinical Neurophysiology, Karolinska University Hospital, Stockholm, Sweden. lars.hyllienmark@karolinska.se
Maltez
J
J
Dandenell
A
A
Ludvigsson
J
J
Brismar
T
T
D000293:Adolescent; D017668:Age of Onset; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000503:physiopathology*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology*; D004569:Electroencephalography; D006801:Humans; D007003:Hypoglycemia / Q000503:physiopathology*; D009046:Motor Neurons / Q000502:physiology; D009431:Neural Conduction / Q000502:physiology; D009475:Neurons, Afferent / Q000502:physiology; D010543:Peroneal Nerve / Q000503:physiopathology; D013497:Sural Nerve / Q000503:physiopathology
D001786:Blood Glucose
Neuropadiatrie. 1971 Jul;3(1):11-45
5170965
Diabetes. 1993 Feb;42(2):341-4
8425671
J Comp Neurol. 1993 Jul 15;333(3):375-97
8349849
J Child Neurol. 1995 Jul;10(4):330-4
7594270
Electroencephalogr Clin Neurophysiol. 1995 Oct;97(5):208-14
7489681
Am J Med. 1991 Apr;90(4):450-9
2012085
Diabetes. 1998 Dec;47(12):1909-14
9836523
Science. 2003 Apr 18;300(5618):502-5
12702880
Prog Neurobiol. 1991;36(5):343-62
1887067
Neurophysiol Clin. 2004 Dec;34(5):195-202
15639128
J Biol Chem. 1999 Dec 3;274(49):34893-902
10574963
Diabetologia. 1993 Apr;36(4):329-34
8477878
Psychoneuroendocrinology. 2000 Jan;25(1):85-105
10633537
Diabetologia. 2000 Apr;43(4):500-6
10819245
Acta Paediatr Scand Suppl. 1977;(270):91-6
278470
Lancet Neurol. 2004 Mar;3(3):169-78
14980532
Diabetologia. 1990 Mar;33(3):152-7
2184066
Diabetologia. 2002 Jan;45(1):108-14
11845229
Brain Res. 2002 Aug 16;946(2):221-31
12137925
N Engl J Med. 1993 Sep 30;329(14 ):977-86
8366922
Acta Neurol Scand. 1996 Jun;93(6):398-402
8836300
Diabetes. 1953 Mar-Apr;2(2):93-9
13033638
Diabetes. 1992 Jan;41(1):107-13
1727729
Diabetologia. 1991 May;34(5):337-44
1864488
Pediatrics. 1985 May;75(5):921-7
3991281
Diabetologia. 1995 Jun;38(6):685-92
7672490
Neurology. 1999 Dec 10;53(9):1937-42
10599761
Diabet Med. 1998 Jan;15(1):30-7
9472861
Ann Intern Med. 1996 Feb 15;124(4):379-88
8554246
Neuroreport. 2002 Dec 20;13(18):2469-73
12499851
N Engl J Med. 1994 Jan 6;330(1):15-8
8259139